Calcipotriene And Betamethasone Dipropionate
Pricing Report NDC 45802-989-96

Latest NADAC: $7.68226 per GM · Effective Mar 17, 2021 · Est. package price $460.94 (60 GM)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Calcipotriene And Betamethasone Dipropionate (NDC 45802-989-96) is $7.68226 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Mar 17, 2021.

As a provided by Padagis Israel Pharmaceuticals Ltd, this medication is distributed in a 1 TUBE in 1 CARTON / 60 g in 1 TUBE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$7.68226
Per GM

Effective Date
Mar 17, 2021
Billable Units
60 GM
Estimated Package Price
$460.94
Data Status
As of Apr 28, 2021
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 TUBE in 1 CARTON / 60 g in 1 TUBE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jun 2014, the NADAC wholesale price for (NDC ) has moved within a range of $4.67517 to $10.31886 per GM. Over this 6 years and 8 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$4.6752 - $10.0917
Market Volatility
115.86% Variance
Latest Trend
2.88%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Mar 17, 2021 $7.68226 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 17, 2021 $7.68226 GMC/I - Chain or Independent PharmacyCode 4, 5, 6G - Generic
Feb 17, 2021 $7.46728 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 20, 2021 $7.75083 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 23, 2020 $5.19503 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 21, 2020 $8.61491 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 21, 2020 $8.61491 GMC/I - Chain or Independent PharmacyCode 4, 5, 6G - Generic
Sep 23, 2020 $4.67517 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 23, 2020 $4.67517 GMC/I - Chain or Independent PharmacyCode 4, 5, 6G - Generic
Sep 23, 2020 $7.51983 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 19, 2020 $7.67819 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 22, 2020 $8.72780 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026